EYPT
Eyepoint Inc
NASDAQ · Pharmaceuticals
$13.30
+0.57 (+4.48%)
Open$13.04
Previous Close$12.73
Day High$13.42
Day Low$12.73
52W High$19.11
52W Low$3.91
Volume—
Avg Volume1.17M
Market Cap1.10B
P/E Ratio—
EPS$-2.99
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
-30.8% upside
Current
$13.30
$13.30
Target
$9.21
$9.21
$6.71
$9.21 avg
$14.14
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 63.63M | 60.36M | 205.52M |
| Net Income | -192,447,167 | -164,297,524 | 48.20M |
| Profit Margin | -302.4% | -287.3% | 23.5% |
| EBITDA | -212,216,754 | -191,240,671 | 61.03M |
| Free Cash Flow | — | — | 35.62M |
| Rev Growth | +5.4% | +5.4% | +1.6% |
| Debt/Equity | — | — | 0.22 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |